Ronald J. Daniels serves as Executive at BridgeBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Ronald J. Daniels has executed 5 insider transactions totaling $4.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 6, 2025 involved exercising options for 61,031 shares valued at $2.1M.
Ronald J. Daniels currently holds 78,022 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald J. Daniels has been a net seller of BBIO stock. They have purchased $298.7K and sold $4.0M worth of shares.
Ronald J. Daniels's most recent insider trade was on Nov 6, 2025, when they sold 61,031 shares at $34.65 per share.
Get notified when new Form 4 filings are submitted
| $63.72 |
| Discretionary |
| Dec 30, 2021 | BBIO | $149.2K | Purchase | 10,402 | $14.34 | Discretionary |
| Dec 28, 2021 | BBIO | $150.3K | Sale | 11,745 | $12.80 | Discretionary |
| Dec 28, 2021 | BBIO | $149.5K | Purchase | 11,745 | $12.73 | Discretionary |